BRUNI, COSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.020
EU - Europa 4.510
AS - Asia 3.965
SA - Sud America 483
Continente sconosciuto - Info sul continente non disponibili 196
AF - Africa 102
OC - Oceania 46
Totale 15.322
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.872
RU - Federazione Russa 1.540
IT - Italia 1.276
CN - Cina 1.091
SG - Singapore 1.051
HK - Hong Kong 606
PL - Polonia 584
BR - Brasile 375
VN - Vietnam 329
KR - Corea 313
IE - Irlanda 264
SE - Svezia 193
FR - Francia 163
BD - Bangladesh 145
DE - Germania 135
IN - India 124
FI - Finlandia 123
CA - Canada 86
ID - Indonesia 61
GB - Regno Unito 58
JP - Giappone 58
JO - Giordania 51
AR - Argentina 48
CH - Svizzera 44
AU - Australia 43
NL - Olanda 28
IQ - Iraq 26
TR - Turchia 22
ZA - Sudafrica 22
ES - Italia 21
MX - Messico 19
CO - Colombia 18
RO - Romania 18
CI - Costa d'Avorio 14
MA - Marocco 13
PK - Pakistan 13
UA - Ucraina 12
EC - Ecuador 11
PH - Filippine 11
JM - Giamaica 10
TN - Tunisia 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
NG - Nigeria 9
BJ - Benin 8
EG - Egitto 8
PE - Perù 8
UZ - Uzbekistan 8
CL - Cile 7
BE - Belgio 6
CR - Costa Rica 6
KE - Kenya 6
PT - Portogallo 6
LT - Lituania 5
LV - Lettonia 5
SA - Arabia Saudita 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AT - Austria 4
GT - Guatemala 4
HU - Ungheria 4
NO - Norvegia 4
PA - Panama 4
SV - El Salvador 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
IL - Israele 3
LB - Libano 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
TH - Thailandia 3
AL - Albania 2
BH - Bahrain 2
DZ - Algeria 2
ET - Etiopia 2
IR - Iran 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
MD - Moldavia 2
NI - Nicaragua 2
PR - Porto Rico 2
RS - Serbia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BM - Bermuda 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 15.115
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.268
Ashburn 904
Singapore 789
Warsaw 576
Hong Kong 531
Fairfield 377
Seoul 310
Hefei 277
Florence 257
Dublin 256
San Jose 246
Chandler 226
Woodbridge 202
Beijing 193
Seattle 178
Milan 160
Council Bluffs 135
Houston 135
Cambridge 132
Ho Chi Minh City 109
Moscow 105
Wilmington 103
Rome 99
Lawrence 95
Altamura 90
Los Angeles 90
Buffalo 83
Lauterbourg 83
Princeton 71
The Dalles 64
Helsinki 63
Boston 58
Munich 58
New York 58
Ann Arbor 57
Hanoi 57
Mumbai 50
Shanghai 47
Tokyo 47
Jakarta 43
Kent 40
Naples 40
Melbourne 39
Dallas 37
Paris 37
Turin 37
Chicago 35
São Paulo 35
Turku 29
Pune 28
Boardman 26
Bologna 26
Dong Ket 26
Phoenix 25
Bern 24
Clifton 23
Guangzhou 22
San Diego 20
Toronto 20
Catania 17
Frankfurt am Main 17
Medford 17
Redondo Beach 17
Yubileyny 17
Bengaluru 16
London 16
Falls Church 15
Abidjan 14
Da Nang 14
Johannesburg 14
Montreal 14
Shenzhen 13
West Jordan 13
Bari 12
Cagliari 12
Genoa 12
Lappeenranta 12
Rio de Janeiro 12
Atlanta 11
Orem 11
Palermo 11
Tianjin 11
Timisoara 11
Belo Horizonte 10
Fiesole 10
Figino 10
Manchester 10
Mexico City 10
Miano 10
Norwalk 10
Salt Lake City 10
Brooklyn 9
Haiphong 9
Pisa 9
Redwood City 9
Washington 9
Andover 8
Chennai 8
Cotonou 8
Kingston 8
Totale 9.737
Salva come PNG Salva come JPEG
Nome #
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 375
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 333
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient. 314
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis 281
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction 244
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 243
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 240
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 238
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 217
Alfabetizzazione sanitaria e pazienti affetti da Sclerosi Sistemica 216
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 216
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases 211
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 210
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 208
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 206
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 205
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 199
Calcinosis in systemic sclerosis: subsets, distribution and complications 197
A SYSTEMATIC LITERATURE REVIEW (SLR) ON NURSING SENSITIVE OUTCOMES IN SYSTEMIC SCLEROSIS 195
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 192
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 192
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 191
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 190
A systematic review of the literature on nursing sensitive outcomes in scleroderma: towards a structured path led by a nurse case manager 189
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 187
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 187
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 187
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis 186
DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION 186
Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis–Interstitial Lung Disease: A Systematic Review 180
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 177
Antioxidant agents help primary Raynaud's phenomenon 176
Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis. 175
The safety of iloprost in systemic sclerosis in a real-life experience 175
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database 174
ASSESSMENT OF HEALTH LITERACY IN A COHORT OF SYSTEMIC SCLEROSIS (SSC) PATIENTS 171
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 170
Patient preferences for systemic sclerosis treatment: A descriptive study within an Italian cohort 169
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 169
AB1540-HPR NURSING INTERVENTIONS FOR RHEUMATIC MUSCULOSKELETAL DISEASES (RMDS) PATIENTS ON BIOLOGIC THERAPY: A SYSTEMATIC LITERATURE REVIEW (SLR) 167
Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre 162
Quantiferon (QFT) identifies latent tuberculosis (LTB) but does not help the evaluation of the efficacy of prophylaxis in inflammatory arthritides 162
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases 162
ULTRASOUND (US) EVALUATION OF BOWEL VASCULOPATHY IN SYSTEMIC SCLEROSIS (SSC) 161
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 161
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 160
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 159
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. 158
Prognostic value of lung ultrasound B-lines in systemic sclerosis 158
Oral lactobacillus species in systemic sclerosis 158
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 158
Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression 155
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 154
The renal resistive index: A new biomarker for the follow-up of vascular modifications in systemic sclerosis 152
Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging 151
Combination therapy with Bosentan and Sildenafil improves Raynaud’s phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis 151
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 149
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS) 149
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study 147
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 147
Avascular bone necrosis: An underestimated complication of systemic sclerosis 145
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 144
To develop a definition and validated expert recommendations to diagnose primary heart involvement in systemic sclerosis - preliminary pathway to a T2T approach 143
Switching from rituximab originator to GP2013 or CT-P10 biosimilars in autoimmune rheumatic diseases: drug retention rate and safety data from a multicentric retrospective cohort 140
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience 140
Ultrashort Echo-Time Magnetic Resonance Imaging Sequence in the Assessment of Systemic Sclerosis-Interstitial Lung Disease 137
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 135
Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. 134
The multifaceted problem of pulmonary arterial hypertension in systemic sclerosis 134
Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis. 133
Serum Organ-Specific Anti-Heart and Anti-Intercalated Disk Autoantibodies as New Autoimmune Markers of Cardiac Involvement in Systemic Sclerosis: Frequency, Clinical and Prognostic Correlates 133
Stressful life events at the onset and during the evolution of systemic sclerosis 131
The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancement 131
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 128
Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review 127
Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR center 125
Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. 124
Treatment of ulcers in systemic sclerosis 122
Recent advances steer the future of systemic sclerosis toward precision medicine 122
Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes 119
Lung vascular changes as biomarkers of severity in systemic sclerosis–associated interstitial lung disease 118
Digital Ulcers in Systemic Sclerosis 112
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management 104
The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review 98
Very early and early diagnosis of systemic sclerosis 97
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 93
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study 91
Kidney involvement in systemic sclerosis: From pathogenesis to treatment 84
Patients and physicians differently consider severity and outcomes of systemic sclerosis-associated interstitial lung disease: Results of an international survey 74
The emerging challenge of pain in systemic sclerosis: Similarity to the pain experience reported by Sjőgren’s syndrome patients 70
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY 51
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry 45
Ultrasound evaluation of bowel vasculopathy in systemic sclerosis 34
First‐line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING‐SIR registry 33
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry 24
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort 21
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR) 20
Correction to: Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review 19
Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis 19
A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis 16
Totale 15.322
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.687
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.687
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022400 0 0 32 20 25 46 8 41 19 27 62 120
2022/20231.168 109 285 61 62 61 169 165 39 102 19 50 46
2023/2024867 21 74 97 50 60 134 50 154 22 113 64 28
2024/20254.509 140 439 254 731 1.089 515 216 380 193 144 179 229
2025/20265.781 622 703 555 514 671 192 628 270 375 354 300 597
2026/2027387 225 123 39 0 0 0 0 0 0 0 0 0
Totale 15.322